Making Sense of Contradictory Evidence in Coronavirus Disease 2019 Trials
- 18 February 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial ResultsThe New England Journal of Medicine, 2021
- Remdesivir for the Treatment of Covid-19 — Final ReportThe New England Journal of Medicine, 2020
- Therapeutic versus prophylactic anticoagulation for severe COVID-19: A randomized phase II clinical trial (HESACOVID)Thrombosis Research, 2020
- A living WHO guideline on drugs for covid-19BMJ, 2020
- Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With Coronavirus Disease 2019 (COVID-19)Clinical Infectious Diseases, 2020
- COVID-19 pneumonia: ARDS or not?Critical Care, 2020
- National Trends in Timing of Death Among Patients With Septic Shock, 1994–2014Critical Care Medicine, 2019
- Effect of an Early Resuscitation Protocol on In-hospital Mortality Among Adults With Sepsis and HypotensionJAMA, 2017
- Mortality in Multicenter Critical Care TrialsCritical Care Medicine, 2015
- Mortality after Fluid Bolus in African Children with Severe InfectionThe New England Journal of Medicine, 2011